Lakefront Biotherapeutics

VIE • Healthcare • Biotechnology • Quote as of 06/24/2026 17:32

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeVIE

Market Capitalization1,652.7 mln

Float44.54 mln

Earnings Date08/10/2026

EPS

7.41

Strong

P / E

3.47

Deeply undervalued

Piotroski F-Score

6 / 9

Solid

Beneish M-Score

0.58

Highly suspicious

Relative Strength

66 / 100

Outperforming

Debt / Equity

0.00

Debt-free

Key Fundamentals

EPS7.41

P/E3.47

ROE17.06

RPS15.84

ROIC98.51

ROA13.48

Interest Cover848

EBITDA, mln398

EV / EBITDA-3.48

EV / EBIT-3.48

Revenue, mln1,044

EV / Revenue-1.33

Financial Strength

Altman Z-Score9.93

Piotroski F-Score 6 / 9

Beneish M-Score0.58

Price to Graham Number0.24

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	3.32%	83 / 100
1 Month	7.14%	79 / 100

Quote Details

Last 25.50

Change 0.2 (0.79%)

Open 25.26

Volume 0

Turnover 0

Average Volume 31.9

Financial Ratios

Pre-Tax Profit Margin57

Leverage Ratio1.04

Current Ratio30.48

Price / Book0.51

Price / Tangible Book0.51

Price / Free Cash Flow-5.33

Debt / Equity0.00

Price / Sales1.58

Income / Employee1,081,369

Dividends

DPS0.00

Dividend Yield0.00%

Payout Ratio0%